Bisantrene may be one of the worlds most tested drugs. It has previously been approved in France for AML, but no-one wanted to use it.
The below is from the race website.
Bisantrene is a small molecule anthracene-based chemotherapeutic that was originally developed by American Cyanamid (Lederle Laboratories) in the 1970s & 1980s with the goal of creating a less cardiotoxic/toxic anthracycline-like chemotherapeutic.
The drug was approved in France for relapsed or refractory (R/R) acute myeloid leukemia (AML) in 1990, however it was not commercialised and was lost to the clinical community for over 30 years due to various merger and acquisition transactions.
So your claims dont seem on point at all.
- Forums
- ASX - By Stock
- RAC
- RAC - Charts & Price Action
RAC - Charts & Price Action, page-18023
-
- There are more pages in this discussion • 4,969 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.53 |
Change
-0.050(3.17%) |
Mkt cap ! $259.9M |
Open | High | Low | Value | Volume |
$1.58 | $1.59 | $1.51 | $174.6K | 113.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2372 | $1.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.59 | 141 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2372 | 1.525 |
2 | 14459 | 1.520 |
1 | 660 | 1.515 |
1 | 11000 | 1.505 |
2 | 10030 | 1.500 |
Price($) | Vol. | No. |
---|---|---|
1.585 | 141 | 1 |
1.620 | 2192 | 2 |
1.630 | 6499 | 2 |
1.640 | 4440 | 2 |
1.660 | 20000 | 1 |
Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD & CEO
Charles Armstrong
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online